Maizel Ari

Maizel Ari is listed in filings as Chief Commercial Officer at Axsome Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 23, 2026, including sale activity. Recent filings connect the profile to Axsome Therapeutics, Inc. (AXSM). The current snapshot covers public activity from Feb 25, 2025 to Apr 23, 2026. Reported amounts are shown as $1.1M to $530.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.